ImThera Medical, now a part of LivaNova

ImThera Medical, based in San Diego, California, is a medical device company founded in 2007 that specializes in neurostimulation therapies for patients with Obstructive Sleep Apnea (OSA). The company aims to enhance the lives of OSA patients by offering alternatives to traditional treatments, addressing the health complications and costs associated with the condition. The flagship product, the THN Sleep Therapy System, is an implantable device that delivers electrical stimulation to the tongue muscles during sleep. This stimulation helps to open the upper airway, significantly reducing or eliminating apnea events. This innovative approach provides a solution for patients who struggle with standard Continuous Positive Airway Pressure (CPAP) therapy. In December 2017, ImThera Medical was acquired by LivaNova, a global medical device manufacturer. This acquisition allows ImThera to integrate its neurostimulation technology into LivaNova's broader portfolio, which includes products for cardiac surgery and neuromodulation. The company has completed clinical trials in the European Union and is pursuing regulatory approvals with the U.S. Food and Drug Administration (FDA).

• Employees 2
• Founded 2008
• Annual Revenue $7000000
• Total Funding $10324107